|

Carboplatin plus Paclitaxel Clinical Trials

2 actively recruiting trials

No change since May 2026

Pipeline

Phase 2: 2

Top Sponsors

  • The University of Hong Kong2

Indications

  • Fallopian Tube Cancer2
  • Ovarian Cancer2
  • Cancer2
  • Primary Peritoneal Carcinoma1
  • Peritoneal Cancer1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.